I commiserate with you and all other holders here. The release...

First 22 Last

Share
Profile

Follow
iggyk

59 Posts.

13

03/03/21

12:29

Post #: 51481199
Share

Originally posted by jwoody1000: ↑

Can only agree with the many posts to today with confusion... and the 'but' about todays (market sensitive) annoucement. The missing info we were expecting ...the many queires that don't quite gel. (think there is a pun in there). I have a cynical view point today.
I have been part of a business community ...and left many times with 'queries' in the void space of a needs to be done and out there.

While the news is a good (great) platform to bounce off from lauch prespective......

WHERE IS OUT MARKETING AND MEIDA people. apparently Boston only do interviews with 24 people to whether people would like to take and buy viraleze...and then don't use mainstream media to release and promote those findings......wonder what the bill will be for that? a mil... and was it all done remotely via zoom.. but still get charged for a plane trip of two..... did they work and still are working for the tainted Trump camp? fully Cynical there.

we were supposed to have result re mutants/variants (specifically the following) but instead get this......(I thought it was said by JF that were testing for these)

"is expected to retain activity against the important SARS-CoV-2 strains being reported
in the UK, South Africa and elsewhere." Our annoucement should have, listed, and said were active against these!?

Of course this needed to be market sensitive... there are media outlets that survey the markets via market sensitive announcements,
what it purposally not release so....Government all over the world need to be hearing this, it is supressed news.... it should be shouted from the tops of mountains... I hope the reasoning will be a major pharma partnership is on board... and wants to do all that the promotion... that would sort of make sense.

Also....the use in 'future' outbreaks. it seems to be part of the dogma of a political campign spiel as the catch line seems to have been used so much. ....don't worry about future.....we have an epidemic NOW.
on track to release to first quarter?... while its been stated that why for sometime..after a suggetive Janurary release.. has this first Quarter been been stretched out... as March ..being in the first quarter had been mentioned recently.... or suggested.... and why not say March instead as that what March means. 3.5 weeks to go.
is the constant use of 'future' epidemics an prompt to a release beyond 1stQ...delays... it is needed now...
and instead of the stupid suggestions of a vac certicate to allow travel or right of access....while still being able to carry and spread the virus (makes me angry with this approach)......use viraleze.
i rant to much to make enough sense today

Expand

I commiserate with you and all other holders here. The release also refers to March as if it lies in the future. The disparity between the greatness of Viraleze and the soporific management & marketing is truly sad.

SPL Price at posting: $2.09 Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What's causing the cost-of-living crisis, and how to navigate it

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk